Zinc in PDB 2j2s: Solution Structure of the Nonmethyl-Cpg-Binding Cxxc Domain of the Leukaemia-Associated Mll Histone Methyltransferase
Zinc Binding Sites:
The binding sites of Zinc atom in the Solution Structure of the Nonmethyl-Cpg-Binding Cxxc Domain of the Leukaemia-Associated Mll Histone Methyltransferase
(pdb code 2j2s). This binding sites where shown within
5.0 Angstroms radius around Zinc atom.
In total 2 binding sites of Zinc where determined in the
Solution Structure of the Nonmethyl-Cpg-Binding Cxxc Domain of the Leukaemia-Associated Mll Histone Methyltransferase, PDB code: 2j2s:
Jump to Zinc binding site number:
1;
2;
Zinc binding site 1 out
of 2 in 2j2s
Go back to
Zinc Binding Sites List in 2j2s
Zinc binding site 1 out
of 2 in the Solution Structure of the Nonmethyl-Cpg-Binding Cxxc Domain of the Leukaemia-Associated Mll Histone Methyltransferase
Mono view
Stereo pair view
|
A full contact list of Zinc with other atoms in the Zn binding
site number 1 of Solution Structure of the Nonmethyl-Cpg-Binding Cxxc Domain of the Leukaemia-Associated Mll Histone Methyltransferase within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Zn2215
b:0.0
occ:1.00
|
HG
|
A:CYS1167
|
1.8
|
0.0
|
1.0
|
SG
|
A:CYS1167
|
2.2
|
0.0
|
1.0
|
SG
|
A:CYS1170
|
2.2
|
0.0
|
1.0
|
SG
|
A:CYS1173
|
2.3
|
0.0
|
1.0
|
SG
|
A:CYS1189
|
2.3
|
0.0
|
1.0
|
HG
|
A:CYS1170
|
2.9
|
0.0
|
1.0
|
H
|
A:CYS1167
|
3.0
|
0.0
|
1.0
|
HB2
|
A:CYS1173
|
3.0
|
0.0
|
1.0
|
H
|
A:MET1191
|
3.2
|
0.0
|
1.0
|
H
|
A:GLY1168
|
3.3
|
0.0
|
1.0
|
CB
|
A:CYS1173
|
3.3
|
0.0
|
1.0
|
HA
|
A:CYS1189
|
3.3
|
0.0
|
1.0
|
H
|
A:LYS1190
|
3.3
|
0.0
|
1.0
|
H
|
A:CYS1170
|
3.4
|
0.0
|
1.0
|
CB
|
A:CYS1189
|
3.4
|
0.0
|
1.0
|
HB2
|
A:CYS1189
|
3.4
|
0.0
|
1.0
|
HB3
|
A:CYS1170
|
3.4
|
0.0
|
1.0
|
CB
|
A:CYS1167
|
3.5
|
0.0
|
1.0
|
CB
|
A:CYS1170
|
3.5
|
0.0
|
1.0
|
HB3
|
A:CYS1167
|
3.5
|
0.0
|
1.0
|
N
|
A:CYS1167
|
3.6
|
0.0
|
1.0
|
H
|
A:CYS1173
|
3.7
|
0.0
|
1.0
|
CA
|
A:CYS1189
|
3.8
|
0.0
|
1.0
|
H
|
A:VAL1169
|
3.8
|
0.0
|
1.0
|
HG3
|
A:MET1191
|
3.9
|
0.0
|
1.0
|
N
|
A:LYS1190
|
3.9
|
0.0
|
1.0
|
HB2
|
A:MET1191
|
3.9
|
0.0
|
1.0
|
HG2
|
A:MET1191
|
3.9
|
0.0
|
1.0
|
HB3
|
A:CYS1173
|
4.0
|
0.0
|
1.0
|
CA
|
A:CYS1167
|
4.1
|
0.0
|
1.0
|
N
|
A:GLY1168
|
4.1
|
0.0
|
1.0
|
N
|
A:CYS1170
|
4.1
|
0.0
|
1.0
|
C
|
A:CYS1189
|
4.2
|
0.0
|
1.0
|
N
|
A:MET1191
|
4.2
|
0.0
|
1.0
|
HA
|
A:ASP1166
|
4.2
|
0.0
|
1.0
|
HB2
|
A:ASN1172
|
4.2
|
0.0
|
1.0
|
HB2
|
A:LYS1190
|
4.3
|
0.0
|
1.0
|
N
|
A:CYS1173
|
4.3
|
0.0
|
1.0
|
HB2
|
A:CYS1170
|
4.3
|
0.0
|
1.0
|
CG
|
A:MET1191
|
4.3
|
0.0
|
1.0
|
HB3
|
A:CYS1189
|
4.3
|
0.0
|
1.0
|
HB2
|
A:CYS1167
|
4.3
|
0.0
|
1.0
|
CA
|
A:CYS1173
|
4.4
|
0.0
|
1.0
|
CA
|
A:CYS1170
|
4.4
|
0.0
|
1.0
|
HB3
|
A:ASP1166
|
4.5
|
0.0
|
1.0
|
C
|
A:ASP1166
|
4.6
|
0.0
|
1.0
|
C
|
A:CYS1167
|
4.6
|
0.0
|
1.0
|
CB
|
A:MET1191
|
4.6
|
0.0
|
1.0
|
HG21
|
A:VAL1169
|
4.6
|
0.0
|
1.0
|
HG3
|
A:LYS1190
|
4.7
|
0.0
|
1.0
|
H
|
A:ARG1192
|
4.7
|
0.0
|
1.0
|
HA
|
A:CYS1173
|
4.7
|
0.0
|
1.0
|
N
|
A:VAL1169
|
4.7
|
0.0
|
1.0
|
CA
|
A:LYS1190
|
4.8
|
0.0
|
1.0
|
CA
|
A:ASP1166
|
4.8
|
0.0
|
1.0
|
HG3
|
A:ARG1192
|
4.9
|
0.0
|
1.0
|
O
|
A:CYS1170
|
4.9
|
0.0
|
1.0
|
CB
|
A:LYS1190
|
5.0
|
0.0
|
1.0
|
C
|
A:CYS1170
|
5.0
|
0.0
|
1.0
|
|
Zinc binding site 2 out
of 2 in 2j2s
Go back to
Zinc Binding Sites List in 2j2s
Zinc binding site 2 out
of 2 in the Solution Structure of the Nonmethyl-Cpg-Binding Cxxc Domain of the Leukaemia-Associated Mll Histone Methyltransferase
Mono view
Stereo pair view
|
A full contact list of Zinc with other atoms in the Zn binding
site number 2 of Solution Structure of the Nonmethyl-Cpg-Binding Cxxc Domain of the Leukaemia-Associated Mll Histone Methyltransferase within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Zn2216
b:0.0
occ:1.00
|
HG
|
A:CYS1158
|
1.7
|
0.0
|
1.0
|
SG
|
A:CYS1161
|
2.2
|
0.0
|
1.0
|
SG
|
A:CYS1158
|
2.3
|
0.0
|
1.0
|
SG
|
A:CYS1155
|
2.3
|
0.0
|
1.0
|
SG
|
A:CYS1194
|
2.3
|
0.0
|
1.0
|
H
|
A:GLY1156
|
2.4
|
0.0
|
1.0
|
HG
|
A:CYS1155
|
2.6
|
0.0
|
1.0
|
HB2
|
A:CYS1161
|
3.0
|
0.0
|
1.0
|
H
|
A:CYS1155
|
3.1
|
0.0
|
1.0
|
H
|
A:CYS1158
|
3.2
|
0.0
|
1.0
|
HB3
|
A:ARG1154
|
3.2
|
0.0
|
1.0
|
CB
|
A:CYS1161
|
3.2
|
0.0
|
1.0
|
H
|
A:CYS1161
|
3.2
|
0.0
|
1.0
|
HB2
|
A:CYS1194
|
3.3
|
0.0
|
1.0
|
H
|
A:GLN1157
|
3.3
|
0.0
|
1.0
|
HB3
|
A:CYS1158
|
3.4
|
0.0
|
1.0
|
CB
|
A:CYS1194
|
3.4
|
0.0
|
1.0
|
N
|
A:GLY1156
|
3.4
|
0.0
|
1.0
|
CB
|
A:CYS1158
|
3.5
|
0.0
|
1.0
|
H
|
A:GLN1195
|
3.5
|
0.0
|
1.0
|
H
|
A:ASN1196
|
3.5
|
0.0
|
1.0
|
HA
|
A:CYS1194
|
3.5
|
0.0
|
1.0
|
N
|
A:CYS1155
|
3.6
|
0.0
|
1.0
|
O
|
A:ASN1196
|
3.7
|
0.0
|
1.0
|
CB
|
A:CYS1155
|
3.8
|
0.0
|
1.0
|
N
|
A:CYS1158
|
3.9
|
0.0
|
1.0
|
CA
|
A:CYS1194
|
4.0
|
0.0
|
1.0
|
N
|
A:CYS1161
|
4.0
|
0.0
|
1.0
|
HB3
|
A:CYS1161
|
4.0
|
0.0
|
1.0
|
CA
|
A:CYS1155
|
4.1
|
0.0
|
1.0
|
HA2
|
A:GLY1156
|
4.1
|
0.0
|
1.0
|
N
|
A:GLN1157
|
4.2
|
0.0
|
1.0
|
CA
|
A:CYS1161
|
4.2
|
0.0
|
1.0
|
CB
|
A:ARG1154
|
4.2
|
0.0
|
1.0
|
N
|
A:GLN1195
|
4.2
|
0.0
|
1.0
|
CA
|
A:CYS1158
|
4.2
|
0.0
|
1.0
|
C
|
A:CYS1155
|
4.2
|
0.0
|
1.0
|
CA
|
A:GLY1156
|
4.3
|
0.0
|
1.0
|
HB2
|
A:CYS1158
|
4.3
|
0.0
|
1.0
|
HA
|
A:ARG1154
|
4.3
|
0.0
|
1.0
|
HB3
|
A:CYS1194
|
4.3
|
0.0
|
1.0
|
C
|
A:ARG1154
|
4.3
|
0.0
|
1.0
|
HB3
|
A:CYS1155
|
4.4
|
0.0
|
1.0
|
N
|
A:ASN1196
|
4.4
|
0.0
|
1.0
|
HD22
|
A:LEU1197
|
4.5
|
0.0
|
1.0
|
HB2
|
A:CYS1155
|
4.5
|
0.0
|
1.0
|
CA
|
A:ARG1154
|
4.5
|
0.0
|
1.0
|
HB3
|
A:ASN1196
|
4.5
|
0.0
|
1.0
|
HA
|
A:CYS1161
|
4.6
|
0.0
|
1.0
|
C
|
A:ASN1196
|
4.6
|
0.0
|
1.0
|
C
|
A:CYS1194
|
4.6
|
0.0
|
1.0
|
HB2
|
A:ARG1154
|
4.6
|
0.0
|
1.0
|
H
|
A:GLY1160
|
4.7
|
0.0
|
1.0
|
C
|
A:GLY1156
|
4.7
|
0.0
|
1.0
|
HG
|
A:LEU1197
|
4.8
|
0.0
|
1.0
|
C
|
A:CYS1158
|
4.9
|
0.0
|
1.0
|
C
|
A:GLN1157
|
4.9
|
0.0
|
1.0
|
HG2
|
A:ARG1154
|
5.0
|
0.0
|
1.0
|
HA3
|
A:GLY1160
|
5.0
|
0.0
|
1.0
|
O
|
A:CYS1158
|
5.0
|
0.0
|
1.0
|
|
Reference:
M.D.Allen,
C.G.Grummitt,
C.Hilcenko,
S.Y.Min,
L.M.Tonkin,
C.M.Johnson,
S.M.Freund,
M.Bycroft,
A.J.Warren.
Solution Structure of the Nonmethyl-Cpg-Binding Cxxc Domain of the Leukaemia-Associated Mll Histone Methyltransferase Embo J. V. 25 4503 2006.
ISSN: ISSN 0261-4189
PubMed: 16990798
DOI: 10.1038/SJ.EMBOJ.7601340
Page generated: Thu Oct 17 01:05:50 2024
|